logo.webp

Welcome To Dawaa Dost

Enter your mobile number to continue

You want to Leave?

1% OFF Save ₹2333
Kadcyla 160mg Injection
Kadcyla 160mg Injection

Kadcyla 160mg Injection

by Roche Products India Pvt Ltd

₹231045 ₹233378

Out of Stock • people bought this

100% Genuine

Delivery : 2-4 days PAN India

Seller : Davadost pharma private limited

Discover the Benefits of ABHA Card registration

Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!

Create ABHA

Introduction to Kadcyla 160mg Injection

Kadcyla 160mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include tiredness, nausea, musculoskeletal (bone, muscle or joint) pain, and bleeding. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.

Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

How Kadcyla 160mg Injection works

Kadcyla 160mg Injection is an anti-cancer medicine. It binds to HER2 receptors on breast cancer cells and flags the cancer cells for destruction by the bodys immune system. It also goes into the cancer cells to release a chemotherapy medicine (emtansine) and stop them from growing and dividing.

How To Use Kadcyla 160mg Injection

  • Your doctor or nurse will give you this medicine. Kindly do not self administer.

Uses of Kadcyla 160mg Injection

  • Breast cancer

Side Effects Of Kadcyla 160mg Injection

  • Tiredness
  • Nausea
  • Musculoskeletal (bone, muscle or joint) pain
  • Bleeding
  • Low blood platelets
  • Headache
  • Liver disorder
  • Constipation
  • Nosebleeds

Safety Advice for Kadcyla 160mg Injection

  • High risk
  • Moderate risk
  • Safe
safetyAdvice.iconUrl

It is not known whether it is safe to consume alcohol with Kadcyla 160mg Injection. Please consult your doctor.

safetyAdvice.iconUrl

Kadcyla 160mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

safetyAdvice.iconUrl

Kadcyla 160mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

safetyAdvice.iconUrl

Kadcyla 160mg Injection does not usually affect your ability to drive.

safetyAdvice.iconUrl

There is limited information available on the use of Kadcyla 160mg Injection in patients with kidney disease. Please consult your doctor.

safetyAdvice.iconUrl

Kadcyla 160mg Injection should be used with caution in patients with severe liver disease. Dose adjustment of Kadcyla 160mg Injection may be needed. Please consult your doctor.

FAQ's on Kadcyla 160mg Injection

What is the use of Kadcyla?

Kadcyla is used to treat HER2-positive breast cancer that has spread to other parts of the body (metastatic breast cancer) after prior treatment with trastuzumab and a taxane.

How is Kadcyla different?

Kadcyla is a conjugate of the HER2 directed trastuzumab and a highly toxic microtubule-targeted drug (emtansine). Thus it is made up of 2 cancer-fighting agents in 1 medicine- The monoclonal antibody trastuzumab and a chemotherapy emtansine. Kadcyla brings chemotherapy medicine (emtansine) into HER2-positive cells and kills them. It is designed to cause less harm to normal cells.
whatsapp-icon